ALMS·022307102·US·equity·Healthcare - Biotechnology-Activist
ALMS (Alumis Inc.) is held by 73 institutional investors as of Q4 2025. Largest holders: BlackRock, Inc. ($44.6M), VANGUARD GROUP INC ($40M), BAKER BROS. ADVISORS LP ($15.3M). Net institutional sentiment: Mixed.
See how ALMS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer